Access

Letter

Nature 440, 702-706 (30 March 2006) | doi:10.1038/nature04585; Received 31 October 2005; Accepted 18 January 2006

Open Innovation Challenges

  • Single-cell Analysis Platform

    • Deadline: Dec 02 2009
    • Reward: $5,000 USD

    This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...

  • Methods to Analyze Consumer Emotions

    • Deadline: Jan 17 2010
    • Reward: $10,000 USD

    The Seeker is looking for methods to analyze consumer emotions. This Challenge requires only a writ...

naturejobs

Oncogenic activity of Cdc6 through repression of the INK4/ARF locus

Susana Gonzalez1, Peter Klatt1, Sonia Delgado4, Esther Conde2, Fernando Lopez-Rios5, Montserrat Sanchez-Cespedes2, Juan Mendez3, Francisco Antequera4 & Manuel Serrano1

  1. Tumor Suppression Group,
  2. Lung Cancer Group, and
  3. DNA Replication Group, Spanish National Cancer Research Center (CNIO), E-28029 Madrid, Spain
  4. Instituto de Microbiología Bioquímica, CSIC/Universidad de Salamanca, E-37007 Salamanca, Spain
  5. Departamento de Anatomía Patológica, Hospital Universitario "12 de Octubre", E-28041 Madrid, Spain

Correspondence to: Manuel Serrano1 Correspondence and requests for materials should be addressed to M.S. (Email: mserrano@cnio.es).

Top

The INK4/ARF locus encodes three tumour suppressors (p15INK4b, ARF and p16INK4a) and is among the most frequently inactivated loci in human cancer1, 2. However, little is known about the mechanisms that govern the expression of this locus. Here we have identified a putative DNA replication origin at the INK4/ARF locus that assembles a multiprotein complex containing Cdc6, Orc2 and MCMs, and that coincides with a conserved noncoding DNA element (regulatory domain RDINK4/ARF). Targeted and localized RNA-interference-induced heterochromatinization of RDINK4/ARF results in transcriptional repression of the locus, revealing that RDINK4/ARF is a relevant transcriptional regulatory element. Cdc6 is overexpressed in human cancers, where it might have roles in addition to DNA replication3, 4, 5. We have found that high levels of Cdc6 result in RDINK4/ARF-dependent transcriptional repression, recruitment of histone deacetylases and heterochromatinization of the INK4/ARF locus, and a concomitant decrease in the expression of the three tumour suppressors encoded by this locus. This mechanism is reminiscent of the silencing of the mating-type HM loci in yeast by replication factors6. Consistent with its ability to repress the INK4/ARF locus, Cdc6 has cellular immortalization activity and neoplastic transformation capacity in cooperation with oncogenic Ras. Furthermore, human lung carcinomas with high levels of Cdc6 are associated with low levels of p16INK4a. We conclude that aberrant expression of Cdc6 is oncogenic by directly repressing the INK4/ARF locus through the RDINK4/ARF element.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.